- Home
- ETON vs MFH Comparison
ETON vs MFH Comparison
Compare ETON & MFH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ETON
- MFH
- Stock Information
- Founded
- ETON 2017
- MFH 2011
- Country
- ETON United States
- MFH United States
- Employees
- ETON N/A
- MFH N/A
- Industry
- ETON Biotechnology: Pharmaceutical Preparations
- MFH Finance: Consumer Services
- Sector
- ETON Health Care
- MFH Finance
- Exchange
- ETON Nasdaq
- MFH Nasdaq
- Market Cap
- ETON 428.5M
- MFH 372.5M
- IPO Year
- ETON 2018
- MFH N/A
- Fundamental
- Price
- ETON $17.07
- MFH $5.98
- Analyst Decision
- ETON Strong Buy
- MFH
- Analyst Count
- ETON 3
- MFH 0
- Target Price
- ETON $27.67
- MFH N/A
- AVG Volume (30 Days)
- ETON 231.3K
- MFH 99.3K
- Earning Date
- ETON 05-13-2025
- MFH 05-23-2025
- Dividend Yield
- ETON N/A
- MFH N/A
- EPS Growth
- ETON N/A
- MFH N/A
- EPS
- ETON N/A
- MFH N/A
- Revenue
- ETON $39,011,000.00
- MFH $1,007,430.00
- Revenue This Year
- ETON $92.33
- MFH N/A
- Revenue Next Year
- ETON $54.19
- MFH N/A
- P/E Ratio
- ETON N/A
- MFH N/A
- Revenue Growth
- ETON 23.29
- MFH 125.92
- 52 Week Low
- ETON $3.18
- MFH $1.03
- 52 Week High
- ETON $18.41
- MFH $8.86
- Technical
- Relative Strength Index (RSI)
- ETON 62.16
- MFH 46.29
- Support Level
- ETON $16.43
- MFH $5.30
- Resistance Level
- ETON $17.74
- MFH $6.68
- Average True Range (ATR)
- ETON 0.92
- MFH 0.81
- MACD
- ETON 0.06
- MFH -0.12
- Stochastic Oscillator
- ETON 73.09
- MFH 26.15
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.
About MFH Mercurity Fintech Holding Inc.
Mercurity Fintech Holding Inc is a New York-based digital fintech leader providing access to the rapidly growing AI-powered infrastructure, blockchain, and digital assets sectors. Its three core business lines include: 1. Blockchain and digital asset solutions. 2. AI and HPC infrastructure, specializing in developing liquid cooling solutions for AI data centers. 3. Comprehensive financial services.